Wilson Sonsini Goodrich & Rosati represented Circle Pharma in the transaction. Circle Pharma, a clinical-stage biopharmaceutical company, announced the closing of a $90 million Series D...
Circle Pharma’s $90 Million Series D Financing Round
Soleno Therapeutics’ $130 Million Common Stock Offering
Wilson Sonsini Goodrich & Rosati advised Soleno Therapeutics on the offering, and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. advised the underwriters. Soleno Therapeutics, Inc....
Orbillion’s $15 Million Funding Round
Wilson Sonsini Goodrich & Rosati represented Orbillion in the transaction. Cultivated meat start-up Orbillion announced it has raised fresh capital that brings its cumulative funding to $15...
Amring Pharmaceuticals’ Acquisition of Visant Medical
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Amring Pharmaceuticals Inc. on the transaction, and Wilson Sonsini Goodrich & Rosati advised Visant Medical. Amring Pharmaceuticals Inc....
Soleno Therapeutics’ $120 Million Common Stock Offering and Private Placement
Wilson Sonsini Goodrich & Rosati and Cooley advised Soleno Therapeutics on the deal. Soleno Therapeutics, Inc. (Nasdaq:SLNO), (“Soleno”) announced the pricing of the underwritten public offering of...
Senzime’s $44 Million Acquisition of Respiratory Motion
Wilson Sonsini advised Respiratory Motion on the deal. Senzime completed the acquisition of 100 percent of the shares in Respiratory Motion, as was made public on...
Wildtype’s $100 Million Series B Funding Round
Wilson Sonsini represented Wildtype on the deal. Wildtype, a start-up creating sushi-grade cultivated salmon, announced the completion of a $100 million Series B funding round, the...
Enable Injections’ $215 Million Series C Financing
Wilson Sonsini Goodrich & Rosati advised Enable Injections on the deal. Enable Injections, Inc., a company developing and manufacturing the enFuse platform of investigational wearable drug...
$100 Million Series B Round
Wilson Sonsini Goodrich & Rosati advised Humane, Inc. on the deal. Humane, Inc. announced it has raised $100 million in its Series B round, which was...
Saranas’ $12.8 Million Series B Investment
Wilson Sonsini Goodrich & Rosati advised Saranas on the deal, while Latham & Watkins represented Baird Capital. Houston, Texas-based Saranas announced a $12.8 million Series B...
Emboline’s $55 Million Series D Funding
Wilson Sonsini Goodrich & Rosati advised Emboline on the deal. Emboline, Inc., a privately held medical device company focused on reducing stroke and other damage caused...